Sarepta Therapeutics (SRPT) Announces that Briefing Docs for Eteplirsen NDA Were Posted
Tweet Send to a Friend
Sarepta Therapeutics (NASDAQ: SRPT) disclosed the following Friday morning:Item 7.01 Regulation FD Disclosure.On January 15, 2016 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
